Mood & mind, explained.

Editorial summary.

Mood, anxiety and brain fog are not just psychological symptoms in women — they sit on a biological substrate that is partly measurable. Thyroid hormone, B12 and folate, vitamin D, ferritin, cortisol rhythm and the estrogen-progesterone balance through the cycle all influence the systems that produce mood, anxiety and cognitive clarity. None of these is a cause on its own. All of them are inputs worth checking before mood symptoms are attributed to "just stress" or "just hormones" without measurement.

The most consequential pattern is also the most under-tested: subclinical thyroid dysfunction in women. Hashimoto's antibodies can be positive for years before TSH moves out of range, and the mood picture — low energy, low motivation, slowed thinking, mild depression — can predate the textbook thyroid presentation by years. B12 sits in second place; low B12 produces brain fog, low mood and a fatigue picture indistinguishable from depression in some women.

This page walks through what to measure, what each marker contributes, and how to think about cyclical mood patterns (PMS, PMDD, perimenopausal mood volatility) alongside the more constant patterns.

What's typically going on.

Mood, anxiety and cognition run on neurotransmitter systems — serotonin, dopamine, GABA, norepinephrine — that are themselves downstream of a small set of inputs that bloodwork can see. The brain needs adequate thyroid hormone to maintain metabolic rate and energy. It needs B12 and folate to synthesise neurotransmitters and maintain myelin (the insulation around nerve fibers). It needs vitamin D, which has receptors throughout the brain and influences immune signalling that, in turn, influences mood. It needs ferritin-supported oxygen delivery. It needs a regulated cortisol rhythm. And, in women, it runs against a hormonal backdrop that changes weekly through the cycle, monthly through anovulatory months, and yearly through perimenopause.

Thyroid dysfunction is the single most under-recognised contributor to mood symptoms in U.S. women. Hashimoto's — autoimmune thyroid disease — affects an estimated 10% of women, and the antibodies (TPO, thyroglobulin) can be positive for years before TSH moves enough to trigger treatment under standard primary-care thresholds. During that time, the mood and cognitive picture often precedes the metabolic one: low motivation, low mood, slowed thinking, irritability, less interest in things that used to feel rewarding. Patients are reliably told this is depression. It may be, on top of an unrecognised thyroid layer.

B12 deficiency in women presents most often as brain fog and low mood with mild fatigue. Serum B12 is the standard test, but it has known limitations — values in the lower half of the "normal" range can still represent functional deficiency. Methylmalonic acid (MMA) and homocysteine sharpen the picture: both rise when B12 is functionally low, and either can be elevated when serum B12 is still in range. Folate cooperates with B12; one without the other gives a fuller picture than either alone.

Vitamin D's role in mood is increasingly well-established. Receptors throughout the brain, association with seasonal mood patterns, and a meaningful body of evidence linking low 25-OH to higher rates of depressive symptoms. Levels below 30 ng/mL are common in U.S. women, particularly through winter. Worth checking and replacing under medical guidance.

Ferritin sits underneath all of the above. Low iron stores produce the kind of background fatigue that erodes mood independently of any direct mood pathway — when the body is mildly under-oxygenated, the brain runs on a lower power setting. The classic "I'm not depressed, I'm just exhausted" picture often turns out to involve a ferritin under 30 ng/mL.

And then there is the cycle. Premenstrual symptoms — low mood, irritability, anxiety, brain fog — clustering reliably in the luteal phase and lifting once the period starts is normal cyclical variation in many women. When the cluster is severe enough to interfere with work, relationships or daily function, the picture shifts toward PMDD (premenstrual dysphoric disorder), an estimated 3–8% prevalence condition that is real, treatable, and reliably missed. Perimenopause amplifies all of this — hormonal volatility, sleep disruption and progesterone decline often produce new-onset anxiety and depression that gets dismissed as a life-stage phenomenon when it has a measurable hormonal substrate.

"The most consistent mood diagnosis given to women is 'just stress.' The most consistent lab missed is a full thyroid panel. The two aren't unrelated."

The biomarkers worth knowing.

You do not need every marker on this list. You need enough to make sure the addressable physical layer hasn't been skipped. Read together by a qualified healthcare provider, the following panel catches most of the measurable contributors to mood, anxiety and cognitive symptoms in U.S. women.

None of these is useful in isolation. A clinician who reads a TSH of 3.2 mIU/L with positive TPO antibodies alongside low mood, sleep changes and a B12 of 280 pg/mL is in a very different conversation from one who reads "TSH in range, B12 normal."

Common patterns.

4.1 The subclinical thyroid pattern

A woman in her 30s or 40s describes low mood, slowed thinking, less interest in things that used to feel rewarding, and a tiredness that doesn't lift with rest. TSH is upper-normal or slowly rising. TPO antibodies positive. The mood picture predates the metabolic one. The right read is a clinician who treats the antibody story seriously, not who waits for TSH to cross a threshold.

4.2 The B12-folate pattern

Brain fog, low mood, sometimes tingling in hands or feet, sometimes the strange "tongue feels off" sensation. Serum B12 in the lower half of range. MMA or homocysteine elevated. RBC folate borderline. Often missed because serum B12 alone is normal. Treatment — often with B12 by mouth or injection plus folate — can shift the mood and cognitive picture meaningfully within weeks to months.

4.3 The PMDD pattern

Severe mood symptoms clustering reliably in the week before the period, lifting within days of the period starting, recurring cycle after cycle. Bloodwork is often unremarkable; the diagnosis is symptom-based and prospective-tracking-based. The treatable layer here includes SSRIs (often used cyclically), hormonal options, and lifestyle. Worth raising explicitly with a qualified clinician rather than absorbing as personality.

4.4 The perimenopausal mood pattern

A woman between 38 and 52 with new-onset anxiety, intrusive thoughts, mood volatility second half of cycle, sleep fragmentation, and brain fog. Often missed because the timing overlaps with major life stressors. Estradiol oscillates; progesterone is low in anovulatory cycles. The right read here is the perimenopause hub, with bloodwork on top to rule overlapping causes in or out.

4.5 The depleted-floor pattern

A woman in a high-load period — new parent, intense caregiving, demanding work — with persistent low mood, fatigue, and the sense that the system is running on fumes. Ferritin under 30 ng/mL. Vitamin D below 30. Sleep is fragmented. Cortisol rhythm disrupted. The mood symptom is sitting on top of a depleted floor — and the floor is the actually addressable layer.

What to ask your provider.

If your current provider declines the wider workup, a second opinion is reasonable. A women's-health nurse practitioner, an endocrinologist familiar with subclinical thyroid disease, or a menopause-trained clinician for the perimenopausal pattern can each move the conversation onto more useful ground.

When to escalate vs when to track over time.

The mood-and-mind space is the one where the "patient timeline" matters most. Bloodwork is rarely an emergency; mental-health symptoms sometimes are.

Worth a planned conversation. Gradual mood or cognitive changes over months, alongside fatigue or cycle changes. Bloodwork on a calm timeline; re-test six to twelve weeks after any intervention. Track cyclical patterns prospectively if PMS/PMDD is on the table.

Worth sooner — clinically. Persistent depression, intrusive anxiety, panic attacks, sleep that no longer feels restorative, or significant functional impairment at work, with family, or in self-care warrant a qualified clinician promptly. Bloodwork can run alongside, not instead of, that conversation.

Worth urgent — without delay. Suicidal thoughts, intent or planning warrant urgent professional support. In the U.S., 988 reaches the Suicide & Crisis Lifeline. Online education does not substitute for clinical care in this layer.

Worth tracking, not panicking. A borderline lab in someone with mild, manageable mood variation is rarely the whole story. Trending markers six months apart, alongside symptom tracking, gives a more honest picture than a single snapshot.